Journal profile · Medicine-Endocrinology, Diabetes and Metabolism
Frontiers in Endocrinology
ISSN 1664-2392 · Frontiers Media S.A. · UNITED STATES
Frontiers in Endocrinology: CAS Zone 3 · Medicine (2025 upgraded edition); impact factor 5.67; fully open access; APC charged, amount not published; median 59 days to acceptance (199 articles, last 24 months); 2,693 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Frontiers in Endocrinology is published by Frontiers Media S.A. and is in Zone 3 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Ovarian function and disorders, Thyroid Cancer Diagnosis and Treatment and Thyroid Disorders and Treatments, together about 21.5% of its articles. Its main subfields are Endocrinology, Diabetes and Metabolism. (generated from OpenAlex topic counts and CAS ranking data)
Frontiers in Endocrinology is a journal that advances our understanding of the endocrine system and publishes research in novel therapies for prevalent health issues such as obesity, diabetes, disorders affecting the reproductive system, and the endocrinology of aging. Led by Field Chief Editor Jeff M. P. Holly (University of Bristol, UK), Frontiers in Endocrinology is indexed in MEDLINE, PubMed Central (PMC), Scopus and Web of Science (SCIE), among others, and welcomes research contributions in the various domains of endocrinology, bridging the gap between basic molecular structure and cellular communication, to clinical care. Topics include: • adrenal endocrinology • bone research • cancer endocrinology • cardiovascular endocrinology • cellular endocrinology • clinical diabetes • developmental endocrinology • diabetes: molecular mechanisms • endocrinology of aging • experimental endocrinology • gut endocrinology • molecular and structural endocrinology • neuroendocrine science • obesity • pediatric endocrinology • pituitary endocrinology • renal endocrinology • reproduction • systems endocrinology • thyroid endocrinology • translational and clinical endocrinology In particular, the journal welcomes submissions which support and advance the UN’s Sustainable Development Goal (SDG), notably SDG 3: good health and well-being, in the effort to further our understanding as well as the prevention and treatment of hormonal disorders. Manuscripts relating to diseases or disorders that do not relate to hormones are not suitable for publication in this journal. Manuscripts reporting solely bibliometric analyses will not be considered. Authors are still welcome to submit Systematic Reviews using publicly available data, but these must adhere to the PRISMA guidelines and include a completed checklist with submission and have a conclusion related to endocrinology. Similarly meta-analyses must adhere to the PRISMA extension guidelines and include a completed checklist with submission. Frontiers’ journals require that manuscripts primarily comprising computational studies of public data, such as NHANES or Mendelian Randomization studies, must include appropriate validation. Please refer to the Frontiers Standards for research methodology policy, for more information. Manuscripts not adhering to these standards will not be considered. Frontiers in Endocrinology is committed to advancing developments in the field of endocrinology by allowing unrestricted access to article
From the journal's Aims & Scope
Research area (LetPub): Medicine-Endocrinology, Diabetes and Metabolism
Editorial board by country: 1 in mainland China (about 6%); most named United States 5, United Kingdom 3, Italy 2, Mainland China 1, Macau, China 1 (17 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Ovarian function and disordersMedicine7.8%
- Thyroid Cancer Diagnosis and TreatmentMedicine6.9%
- Thyroid Disorders and TreatmentsMedicine6.8%
- Diabetes, Cardiovascular Risks, and LipoproteinsMedicine5.8%
- Reproductive Biology and FertilityMedicine4.9%
- Growth Hormone and Insulin-like Growth FactorsMedicine4.8%
- Adipokines, Inflammation, and Metabolic DiseasesMedicine4.5%
- Pancreatic function and diabetesMedicine4.5%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Endocrinology & Metabolism | Zone 3 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Endocrinology & Metabolism | Zone 2 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Endocrinology & Metabolism | Zone 2 |
Top journal: noReview journal: no
Database indexing
SCIEScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
Web of ScienceMEDLINEPMCEmbasePublisher website
Other: EBSCO, ProQuest, Dimensions, CNKI, CLOCKSS, Crossref
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 5.67LetPub ·
- Impact factor (publisher)
- 5.7Publisher website ·
- CiteScore 2026-06
- 9.1LetPub ·
- CiteScore (publisher)
- 9.1Publisher website ·
- SJR 2026-06
- 1.57LetPub ·
- SNIP 2026-06
- 1.49LetPub ·
- h-index
- 51LetPub ·
- h-index
- 200OpenAlex ·
- i10-index
- 10,149OpenAlex ·
- 2-year mean citedness
- 4.68OpenAlex ·
- Self-citation rate
- 3.5%LetPub ·
- Share of gold OA articles
- 99.91%LetPub ·
Volume
- Articles per year
- 2,481LetPub ·
Articles by year OpenAlex count · 21,624 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 2,853 | 2,853 | 1,160 |
| 2025 | 2,693 | 2,693 | 11,001 |
| 2024 | 2,535 | 2,535 | 25,624 |
| 2023 | 3,381 | 3,381 | 55,475 |
| 2022 | 3,581 | 3,581 | 75,866 |
| 2021 | 1,948 | 1,948 | 60,648 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
59 daysMedian, submission to acceptance · P25–P75 38 days – 79 days
- Acceptance to online
- median 17 days (199 articles)
- Submission to online
- median 78 days
- Sample
- 199 articles with submission and acceptance dates (5,943 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 14 weeksLetPub ·
- Submission to publication (journal-reported)
- about 14 weeksDOAJ ·
- Peer review
- Single anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | CHF 3,150 | Yes | CC BY | |
| OpenAlex | CHF 3,150 | — | — | |
| LetPub | USD 3,295 | Yes | — | |
| Publisher website | Yes, amount not published | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare3 items from the author guidelines
- Keywords
- 5–8
- Reference style
- Harvard
- Templates
- LaTeX and Word
Policy excerpts from the journal's websiteAI use, Conflicts of interest, License & copyright, Open access, Peer review
- AI use Use of AI to create written or visual content
Authors should not list a generative AI technology as a co-author or author of any submitted manuscript. Generative AI technologies cannot be held accountable for all aspects of a manuscript and consequently do not meet the criteria required for authorship. If the author of a submitted manuscript has used written or visual content produced by or edited using a generative AI technology, this use mu…
Source ↗Publisher website ·- Conflicts of interest Safeguards against financial conflicts of interest
Only leading researchers acting as Associate Editors, who are not part of Frontiers' staff, can make acceptance decisions based on reviews performed by external experts acting as Community Reviewers or Reviewers. None have a financial incentive to accept articles, i.e. they are not paid for their role as Associate Editor or community Reviewer, and any award scheme is not linked to acceptances of m…
Source ↗Publisher website ·- License & copyright Open access and copyright
Figures, tables, and images are published under a Creative Commons CC-BY license; permission must be obtained for copyrighted material from other sources. Model summary
All Frontiers' articles from July 2012 onwards are published with open access under the Creative Commons CC-BY license (the current version is CC-BY, version 4.0). This means that the author(s) retains copyright, but the content is free to download, distribute, and adapt for commercial or non-commercial purposes, given appropriate attribution to the original article. Upon submission, the author(s)…
Source ↗Publisher website ·- Open access Open access and copyright
All articles from July 2012 onwards are published open access under the Creative Commons CC-BY license (version 4.0). Model summary
All Frontiers' articles from July 2012 onwards are published with open access under the Creative Commons CC-BY license (the current version is CC-BY, version 4.0). This means that the author(s) retains copyright, but the content is free to download, distribute, and adapt for commercial or non-commercial purposes, given appropriate attribution to the original article. Upon submission, the author(s)…
Source ↗Publisher website ·- Peer review Peer review
CrossMark is applied to maintain published content and alert readers to changes. Model summary
Our rigorous, transparent peer review process combines expert review and constructive dialogue to strengthen your manuscript.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Frontiers Media S.A.
- Country or region
- UNITED STATES
- Language
- English
- ISSN
- 1664-2392
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗Publisher website
- Author guidelines ↗LetPub
- Aims & Scope ↗LetPub
- Special issues ↗Publisher website
- APC information ↗DOAJ
- Fee waivers ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗LetPub
- Editorial board ↗LetPub
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about Frontiers in Endocrinology
What CAS zone is Frontiers in Endocrinology in?
In the 2025 upgraded edition of the CAS Journal Ranking, Frontiers in Endocrinology is in Zone 3 of Medicine, and in Zone 3 of the minor category Endocrinology & Metabolism. In the 2026 Xinrui edition it is in Zone 2 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Frontiers in Endocrinology?
The latest impact factor listed by LetPub is 5.67; CiteScore 9.1, h-index 200.
How long does peer review take at Frontiers in Endocrinology?
Based on the dates recorded on 199 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 59 days (interquartile range 38–79 days); authors report an average review time of about 14 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Frontiers in Endocrinology?
According to the journal's author guidelines: Keywords: 5–8; Reference style: Harvard; Templates: LaTeX and Word. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Frontiers in Endocrinology based?
Of the 17 board members whose country the journal's board page names, 1 (about 6%) are in mainland China; the countries named most often are United States (5), United Kingdom (3) and Italy (2). Counted from the institutions listed on the board page; for reference only.
Which databases index Frontiers in Endocrinology?
According to LetPub and DOAJ records, Frontiers in Endocrinology is indexed in SCIE, Scopus and DOAJ. The journal's website also lists Web of Science, MEDLINE, PMC and Embase; that list has not been checked against each database.
Is Frontiers in Endocrinology open access, and what is the APC?
Frontiers in Endocrinology is a fully open-access journal. APC charged, amount not published.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website, DOAJ; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .